Mitochondrial Abnormalities in Alzheimer’s Disease
- 26 July 2012
- book chapter
- Published by Elsevier
- Vol. 64, 83-126
- https://doi.org/10.1016/b978-0-12-394816-8.00003-9
Abstract
No abstract availableKeywords
This publication has 168 references indexed in Scilit:
- Brain aging, Alzheimer's disease, and mitochondriaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neuronsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?Molecular Neurobiology, 2010
- Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Biochemical effects of SIRT1 activatorsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairmentJournal of Bioenergetics and Biomembranes, 2009
- PGC-1α Expression Decreases in the Alzheimer Disease Brain as a Function of DementiaArchives of Neurology, 2009
- Mitochondrial Medicine for Aging and Neurodegenerative DiseasesNeuroMolecular Medicine, 2008
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007
- Human Coenzyme Q10 DeficiencyNeurochemical Research, 2006